The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030.
Level 5 - mechanism / opinion, no new human data
Expert commission report and narrative review with no new primary data or systematic meta-analysis.
PubMed 34010613 · doi:10.1016/S0140-6736(21)00684-X
What was done
An international commission of experts reviewed and summarized existing evidence regarding cardiovascular disease in women to identify knowledge gaps across research, prevention, diagnosis, treatment, and access to care, formulating recommendations to reduce disease burden by 2030.
What was found
The abstract reports no numerical data or statistics. It reports that cardiovascular disease remains the leading cause of death in women, that global reductions in cardiovascular disease burden among women have stagnated over the past decade, and that the disease in women remains understudied, under-recognized, underdiagnosed, and undertreated.
Why it matters
It highlights persistent global sex- and gender-related disparities in cardiovascular care and provides a coordinated expert agenda to direct future research and clinical interventions.
Limits
The abstract describes an expert commission narrative review without presenting primary empirical data, search methodology, or quantitative synthesis. No sample size or study counts are provided.
Cited by
- supports Cardiovascular disease is the leading cause of death worldwide and is the leading cause of death among women.